首页 | 本学科首页   官方微博 | 高级检索  
     


Randomized,Double-Blind,Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced,Unresectable Chordoma
Authors:Peter Joseph DeMaria  Marijo Bilusic  Deric M. Park  Christopher R. Heery  Renee N. Donahue  Ravi A. Madan  Mohammad Hadi Bagheri  Julius Strauss  Victoria Shen  Jennifer L. Marté  Seth M. Steinberg  Jeffrey Schlom  Mark R. Gilbert  James L. Gulley
Affiliation:1. Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;2. Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Contributed equally.;3. Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

University of Chicago, Chicago, Illinois, USA;4. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;5. Clinical Image Processing Service, National Institutes of Health, Bethesda, Maryland, USA;6. Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;7. Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Abstract:
Keywords:Chordoma  Immunotherapy  Therapeutic vaccine  Radiation therapy  Randomized clinical trial
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号